-
Small-Business Grants Awarded for Neurological Diseases
A biotechnology company spun-off last year in a pharmaceutical industry merger is receiving small business research grants to advance its technology treating neurological disorders.
-
Oxford, Evotec Partner on Drug Discovery
A collaboration between University of Oxford and a German drug discovery company aims to speed promising new treatments to the market, including support for start-up enterprises.
-
Liquid Biopsy Lab to Reside at Cancer Institute
A designer of liquid biopsy tests to diagnose cancer is establishing a lab to study circulating tumor cells at John Wayne Cancer Institute in Santa Monica, California.
-
Florida Voters Give Split Decision on GM Mosquitoes [Updated]
Voters in the Florida Keys yesterday returned a split decision on non-binding ballot questions about testing genetically modified mosquitoes to stop the Zika virus.
-
Phone-Based Microscope Developed for Water Testing
An engineering lab at University of Houston in Texas designed an inexpensive lens that when placed over a smartphone’s camera, turns the phone into a microscope.
-
RNA Drug Delivery Technique Shown Safe in Monkeys
A biotechnology company reports a drug delivery method combining nanoscale lipid particles and biocompatible polymers enables the safe production of synthetic RNA-based proteins in monkeys.
-
Zika Vaccine Clinical Trial Underway
The first of a series of clinical trials testing inactivated Zika particles as a vaccine to protect against the live Zika virus is recruiting participants.
-
Patent Awarded for Cancer-Fighting Antibody
A synthetic engineered antibody developed by MabVax Therapeutics that binds to solid tumor cells for cancer diagnostics and treatment received a U.S. patent.
-
Crowdfunded Digital Health Investment Fund Launches
An investment fund raising its capital through crowdfunding began operations this week to back start-up enterprises developing digital health technologies.
-
Lilly, Institute Partner on Tuberculosis Drug Discovery
Drug maker Eli Lilly and Company is continuing its collaboration with Infectious Disease Research Institute to discovery new drugs that treat tuberculosis.